Moorhouse L, Imai-Eaton J, Dadirai T, Maswera R, Museka T, Mandizvidza P
medRxiv. 2025; .
PMID: 39830272
PMC: 11741482.
DOI: 10.1101/2025.01.08.25320195.
Logie C, Okumu M, Loutet M, Coelho M, McAlpine A, MacKenzie F
BMC Public Health. 2024; 24(1):2599.
PMID: 39334074
PMC: 11429596.
DOI: 10.1186/s12889-024-20135-2.
Moorhouse L, Imai-Eaton J, Maswera R, Tsenesa B, Magoge-Mandizvidza P, Moyo B
medRxiv. 2024; .
PMID: 39281761
PMC: 11398587.
DOI: 10.1101/2024.09.07.24310075.
Humphries H, Knight L, van Heerden A
Prev Med Rep. 2024; 46:102870.
PMID: 39257879
PMC: 11384964.
DOI: 10.1016/j.pmedr.2024.102870.
Auerbach J, Malone S, Forsyth A
J Int AIDS Soc. 2024; 27(8):e26341.
PMID: 39155429
PMC: 11330849.
DOI: 10.1002/jia2.26341.
Advancing Programme Science approaches to understand gaps in HIV prevention programme coverage for key populations in 12 Nigerian states: findings from the 2020 Integrated Biological and Behavioural Surveillance Survey.
McClarty L, Green K, Leung S, Ejeckam C, Adesina A, Shaw S
J Int AIDS Soc. 2024; 27 Suppl 2:e26269.
PMID: 38988042
PMC: 11236907.
DOI: 10.1002/jia2.26269.
Applying the Effective Programme Coverage framework to assess gaps in HIV prevention programmes for female sex workers and men who have sex with men in Nairobi, Kenya: findings from an expanded Polling Booth Survey.
Bhattacharjee P, McClarty L, Isac S, Kimani J, Emmanuel F, Kabuti R
J Int AIDS Soc. 2024; 27 Suppl 2:e26240.
PMID: 38982888
PMC: 11233849.
DOI: 10.1002/jia2.26240.
Analysis of HIV drug prophylaxis services cascade in healthcare workers: a cross-sectional study in China.
Hu J, Kang W, Guo J, Xu J, Lyu F, Zhang G
BMC Infect Dis. 2024; 24(1):4.
PMID: 38166686
PMC: 10759606.
DOI: 10.1186/s12879-023-08873-x.
Factors Associated with COVID-19 Vaccine Uptake among Schoolgoing Adolescent Girls and Young Women in South Africa.
Bergh K, Jonas K, Duby Z, Govindasamy D, Mathews C, Reddy T
Vaccines (Basel). 2023; 11(10).
PMID: 37896983
PMC: 10610973.
DOI: 10.3390/vaccines11101581.
Integrating PrEP in maternal and child health clinics in Kenya: analysis of a service availability and readiness assessment (SARA) survey.
Hicks S, Abuna F, Odhiambo B, Dettinger J, Sila J, Oketch G
Front Reprod Health. 2023; 5:1206150.
PMID: 37484872
PMC: 10359145.
DOI: 10.3389/frph.2023.1206150.
Developing evidence-informed indicators to monitor HIV pre-exposure prophylaxis programmes across EU/EEA countries: a multi-stakeholder consensus.
Vanhamel J, Wijstma E, Deblonde J, Laga M, Vuylsteke B, Nostlinger C
Euro Surveill. 2023; 28(23).
PMID: 37289428
PMC: 10318945.
DOI: 10.2807/1560-7917.ES.2023.28.23.2200546.
Experience with Contraceptive Dosage Forms and Interest in Novel PrEP Technologies in Women.
Jansen van Vuuren C, Lewis L, Harkoo I, Dawood H, Mansoor L
AIDS Behav. 2023; 27(11):3596-3602.
PMID: 37221330
PMC: 10589132.
DOI: 10.1007/s10461-023-04072-6.
Evaluating use of mass-media communication intervention 'MTV-Shuga' on increased awareness and demand for HIV and sexual health services by adolescent girls and young women in South Africa: an observational study.
Chimbindi N, Mthiyane N, Chidumwa G, Zuma T, Dreyer J, Birdthistle I
BMJ Open. 2023; 13(5):e062804.
PMID: 37208144
PMC: 10201230.
DOI: 10.1136/bmjopen-2022-062804.
Process description of developing HIV prevention monitoring indicators for a province-wide pre-exposure prophylaxis (PrEP) program in British Columbia, Canada.
Munasinghe L, Toy J, Lepik K, Moore D, Hull M, Bacani N
PLoS One. 2023; 18(3):e0283025.
PMID: 36920956
PMC: 10016663.
DOI: 10.1371/journal.pone.0283025.
Multilevel model in the identification of behavioral and structural risk factors for HIV: integrative review.
Silva J, Santos J, Moreira W, Romero R, Leadebal O, Nogueira J
Rev Bras Enferm. 2022; 76(1):e20210853.
PMID: 36542051
PMC: 9749773.
DOI: 10.1590/0034-7167-2021-0853.
Integrating Enhanced HIV Pre-exposure Prophylaxis Into a Sexually Transmitted Infection Clinic in Lilongwe: Protocol for a Prospective Cohort Study.
Rutstein S, Matoga M, Chen J, Mathiya E, Ndalama B, Nyirenda N
JMIR Res Protoc. 2022; 11(12):e37395.
PMID: 36469400
PMC: 9764156.
DOI: 10.2196/37395.
The socioeconomic impact of tuberculosis on children and adolescents: a scoping review and conceptual framework.
Atkins S, Heimo L, Carter D, Ribas Closa M, Vanleeuw L, Chenciner L
BMC Public Health. 2022; 22(1):2153.
PMID: 36419146
PMC: 9686126.
DOI: 10.1186/s12889-022-14579-7.
HIV prevention metrics: lessons to be learned from contraception.
Pyra M, Heffron R, Haberer J, Kiarie J
J Int AIDS Soc. 2022; 25(8):e25958.
PMID: 35929343
PMC: 9353407.
DOI: 10.1002/jia2.25958.
Acceptability and feasibility of leveraging community-based HIV counselling and testing platforms for same-day oral PrEP initiation among adolescent girls and young women in Eastern Cape, South Africa.
Medina-Marino A, Bezuidenhout D, Ngwepe P, Bezuidenhout C, Facente S, Mabandla S
J Int AIDS Soc. 2022; 25(7):e25968.
PMID: 35872602
PMC: 9309460.
DOI: 10.1002/jia2.25968.
The association between HIV stigma and HIV incidence in the context of universal testing and treatment: analysis of data from the HPTN 071 (PopART) trial in Zambia and South Africa.
Hargreaves J, Pliakas T, Hoddinott G, Mainga T, Mubekapi-Musadaidzwa C, Donnell D
J Int AIDS Soc. 2022; 25 Suppl 1:e25931.
PMID: 35818869
PMC: 9274206.
DOI: 10.1002/jia2.25931.